Cowen And Company, LLC Neurocrine Biosciences Inc Transaction History

Cowen And Company, LLC

  • $3.88 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$106.07 - $132.76 $1.98 Million - $2.48 Million
18,668 New
18,668 $2.46 Million
Q2 2021

Aug 13, 2021
SELL
$89.43 - $102.27 $316,313 - $361,728
-3,537 Closed
0 $0
Q1 2021

May 04, 2021
BUY
$87.57 - $119.4 $309,735 - $422,317
3,537 New
3,537 $344,000

Others Institutions Holding NBIX

# of Institutions
624
Shares Held
94.2M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email